These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10782338)

  • 1. The exoskeleton of bacterial cells (the sacculus): still a highly attractive target for antibacterial agents that will last for a long time.
    Koch AL
    Crit Rev Microbiol; 2000; 26(1):1-35. PubMed ID: 10782338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Building a bridge to new antibiotics.
    Pohl NL
    ACS Chem Biol; 2006 Feb; 1(1):14-6. PubMed ID: 17163633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The exocytoskeleton.
    Koch AL
    J Mol Microbiol Biotechnol; 2006; 11(3-5):115-25. PubMed ID: 16983189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renew or die: The molecular mechanisms of peptidoglycan recycling and antibiotic resistance in Gram-negative pathogens.
    Domínguez-Gil T; Molina R; Alcorlo M; Hermoso JA
    Drug Resist Updat; 2016 Sep; 28():91-104. PubMed ID: 27620957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli.
    Höltje JV
    Microbiol Mol Biol Rev; 1998 Mar; 62(1):181-203. PubMed ID: 9529891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Were Gram-positive rods the first bacteria?
    Koch AL
    Trends Microbiol; 2003 Apr; 11(4):166-70. PubMed ID: 12706994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bacterial cell wall as a source of antibacterial targets.
    Green DW
    Expert Opin Ther Targets; 2002 Feb; 6(1):1-19. PubMed ID: 11901475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell Wall Deficiency as a Coping Strategy for Stress.
    Claessen D; Errington J
    Trends Microbiol; 2019 Dec; 27(12):1025-1033. PubMed ID: 31420127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-Acetylated peptidoglycan: controlling the activity of bacterial autolysins and lytic enzymes of innate immune systems.
    Moynihan PJ; Clarke AJ
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1655-9. PubMed ID: 21889603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidoglycan plasticity in bacteria: emerging variability of the murein sacculus and their associated biological functions.
    Cava F; de Pedro MA
    Curr Opin Microbiol; 2014 Apr; 18():46-53. PubMed ID: 24607990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro reconstitution of two essential steps in wall teichoic acid biosynthesis.
    Ginsberg C; Zhang YH; Yuan Y; Walker S
    ACS Chem Biol; 2006 Feb; 1(1):25-8. PubMed ID: 17163636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell shape and cell-wall organization in Gram-negative bacteria.
    Huang KC; Mukhopadhyay R; Wen B; Gitai Z; Wingreen NS
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19282-7. PubMed ID: 19050072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PG-Metrics: A chemometric-based approach for classifying bacterial peptidoglycan data sets and uncovering their subjacent chemical variability.
    Kumar K; Espaillat A; Cava F
    PLoS One; 2017; 12(10):e0186197. PubMed ID: 29040278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the response of bacteria to beta-lactam antibiotics.
    Greenwood D
    Rev Infect Dis; 1986; 8 Suppl 5():S487-95. PubMed ID: 3541134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial and hemolytic activities of linenscin OC2, a hydrophobic substance produced by Brevibacterium linens OC2.
    Boucabeille C; Mengin-Lecreulx D; Henckes G; Simonet JM; van Heijenoort J
    FEMS Microbiol Lett; 1997 Aug; 153(2):295-301. PubMed ID: 9271855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic labelling of the carbohydrate core in bacterial peptidoglycan and its applications.
    Liang H; DeMeester KE; Hou CW; Parent MA; Caplan JL; Grimes CL
    Nat Commun; 2017 Apr; 8():15015. PubMed ID: 28425464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How did bacteria come to be?
    Koch AL
    Adv Microb Physiol; 1998; 40():353-99. PubMed ID: 9889982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
    Briers Y; Lavigne R
    Future Microbiol; 2015; 10(3):377-90. PubMed ID: 25812461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.
    Cole EC; Addison RM; Rubino JR; Leese KE; Dulaney PD; Newell MS; Wilkins J; Gaber DJ; Wineinger T; Criger DA
    J Appl Microbiol; 2003; 95(4):664-76. PubMed ID: 12969278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.